pcDNA3 Lats1 (Nigg HS189) Citations (6)
Originally described in: The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1.Chan EH, Nousiainen M, Chalamalasetty RB, Schafer A, Nigg EA, Sillje HH Oncogene. 2005 Mar 17;24(12):2076-86. PubMed Journal
Articles Citing pcDNA3 Lats1 (Nigg HS189)
Articles |
---|
A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells. Qu L, Wu Z, Li Y, Xu Z, Liu B, Liu F, Bao Y, Wu D, Liu J, Wang A, Chu X, Sun Y, Chen C, Zhang Z, Wang L. Nat Commun. 2016 Nov 25;7:12692. doi: 10.1038/ncomms12692. PubMed |
POPX2 is a novel LATS phosphatase that regulates the Hippo pathway. Rahmat MB, Zhang S, Koh CG. Oncotarget. 2019 Feb 19;10(15):1525-1538. doi: 10.18632/oncotarget.26689. eCollection 2019 Feb 19. PubMed |
Galpha13-mediated LATS1 down-regulation contributes to epithelial-mesenchymal transition in ovarian cancer. Yagi H, Onoyama I, Asanoma K, Hori E, Yasunaga M, Kodama K, Kijima M, Ohgami T, Kaneki E, Okugawa K, Yahata H, Kato K. FASEB J. 2019 Dec;33(12):13683-13694. doi: 10.1096/fj.201901278R. Epub 2019 Sep 28. PubMed |
Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma. Slemmons KK, Yeung C, Baumgart JT, Juarez JOM, McCalla A, Helman LJ. Cancer Res. 2020 Jul 15;80(14):3046-3056. doi: 10.1158/0008-5472.CAN-19-3853. Epub 2020 Apr 30. PubMed |
Elucidation of Short Linear Motif-Based Interactions of the FERM Domains of Ezrin, Radixin, Moesin, and Merlin. Ali M, Khramushin A, Yadav VK, Schueler-Furman O, Ivarsson Y. Biochemistry. 2023 Jun 6;62(11):1594-1607. doi: 10.1021/acs.biochem.3c00096. Epub 2023 May 24. PubMed |
Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity. Peng L, Zhou L, Li H, Zhang X, Li S, Wang K, Yang M, Ma X, Zhang D, Xiang S, Duan Y, Wang T, Sun C, Wang C, Lu D, Qian M, Wang Z. Cell Rep. 2024 Apr 23;43(4):114003. doi: 10.1016/j.celrep.2024.114003. Epub 2024 Mar 23. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.